NCT06965426Recruiting
Effect of Lutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation on Skin Carotenoid Concentration: A Six-Month, Placebo-Controlled Crossover Study
Source: ClinicalTrials.gov · Last updated 1 Sept 2026
Brief summary (registry, in English)
To compare skin carotenoid scores over 12 weeks of individuals randomized to placebo or MacuHealth and comparing that to a 12 week crossover evaluation.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 2 May 2025
- Start date
- 1 Jun 2025
- Primary completion date
- 29 Oct 2026
- Lead sponsor
- Insight Eyecare Specialties, Inc. dba Vision Source Eyecare,
- Diseases
- Macular degeneration
- NCT number
- NCT06965426
What you commit to
- Study type: Interventional
- Planned participants: 60
- From 1 Jun 2025 to the primary completion date, 29 Oct 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- History of any non-controlled disease states including diabetes, cancer, heart diseases ETC (we need to confirm this with previous protocols) BMI greater than 30
- Currently taking MacuHealth or similar supplements or previous use
Other
- Current Smoker
- Pregnant, plan to become pregnant or breastfeeding
Who the study is looking for
- Adult patients 18-50 years old of any sex and any race.
- Willing to comply with the protocol instructions.
- Has read (or has had read to), understood, and signed an Informed Consent.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Vision Source Coordinator of this site? Confirm its status | Kansas City | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.